Abstract
Familial Hypercholesterolemia (FH) is a primary dyslipidemia with frequent monogenic inheritance resulting from functional mutations in the Low Density Lipoprotein Receptor (LDLR), apolipoprotein B (APOB) and Proprotein convertase subtilisin/kexin type 9 (PCSK9) genes, which codify proteins that regulate cholesterol homeostasis. The first-line treatment consists of the use of statins, suc…